Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today said it believes the trend established in 2007 for states to legislate that consumers should be made aware of the advantages of umbilical cord blood storage will continue in 2008 and beyond.

New York State in 2007 became the first in the nation to sign into law an Umbilical Cord Blood Bill mandating that the state's Department of Health develop a program to make the public aware of the benefits of umbilical cord blood banking. California subsequently followed, enacting legislation encouraging the collection of umbilical cord blood stem cells.

"Many young couples and growing families do not yet know how important it is to consider storing umbilical cord blood after the birth of a child, even though storing umbilical cord blood could be a life saver if someone in the family develops certain serious diseases," said New York Assemblyman Joseph R. Lentol. "Pregnant women should be receiving information early so they can make an educated decision, especially since there are now more than 60 diseases that can be helped through cord blood transplantation, including leukemia, lymphomas and other cancers."

California Assemblyman Anthony Portantino stressed: "Why are we throwing something away that we know is such a healing product. It has the power to do miracles."

"We look forward to more states requiring their health department to inform families about the benefits of umbilical cord blood storage, which is safe and non-controversial," said Matthew Schissler, CEO, Cord Blood America. "We salute this Coast to Coast effort in providing solid, reliable information to potential new parents."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at . For investor information, visit .

CONTACT:
Paul Knopick
E & E Communications
949/707-5365